21 May 2013
Keywords: scios, nova, starts, bfgf, trials, stroke, started
Article | 15 January 1996
Scios Nova has started a Phase I/II trial of its recombinant basic fibroblast growth factor product, Fiblast (trofermin), as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.